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Abstract
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Introduction
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Plesiomonas shigelloides is a member of the Enterobacteriaceae family generally found in
freshwater. There is little substantive data about the prevalence or distribution of Plesiomonas within the United States. Plesiomonas are most commonly associated with mild,
self-limited watery diarrhea among healthy individuals followed by infective colitis. Bacteremia is the most common extraintestinal manifestation of Plesiomonas. Few cases of
Plesiomonas bacteremia can be found in the literature.
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Clinical Findings

An elderly female with multiple comorbidities was admitted to our hospital for evaluation of
generalized cramping abdominal pain of several days duration. She denied any freshwater or
saltwater exposure. The patient’s labs were significant for leukocytosis and lactic acidosis.
An abdominopelvic CT showed acute colitis of the descending colon.

Outcomes

Surgery was consulted for suspicion of ischemic colitis, and the patient subsequently underwent subtotal colectomy, splenectomy and resection of the distal small bowel with an
ileostomy, as extensive necrotic bowel was found. Blood cultures taken on admission grew
Plesiomonas shigelloides, for which piperacillin-tazobactam was started. Negative blood
cultures were obtained 4 days after positive blood cultures.

Conclusions

Relative rarity and variability of presentation, presence or absence of underlying disease or
exposure to risk factors, and currently limited data utilizing different antimicrobial regimens
contribute to the difficulty in outlining guideline-based regimens for management of Plesiomonas.
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Introduction

Plesiomonas shigelloides is a member of the
Enterobacteriaceae family and is the only species within its genus, having previously been a
member of the Vibrionaceae family. It is oxidase
and nitrate reductase positive, facultatively
anaerobic and acid-producing from m-inositol.1
A protein/lipopolysaccharide complex toxin is
produced by Plesiomonas, which has a cytotoxic
and enteropathogenic effect.2 Some isolates
share the capsular O antigen with Shigella son-

nei. Plesiomonas tends to be found in freshwater (> 0.5% NaCl) and brackish/estuary waters
(0.05%–3% NaCl).
At this time, there is very little substantive
data about the prevalence or distribution of
Plesiomonas within the United States. It is
not part of the human microbiota. It is associated with freshwater exposure resulting in
gastrointestinal, soft-tissue, wound and ocular
infections, as well as bacteremia and meningi-
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Figure 1. CT angiography of the abdomen and pelvis with inflammatory changes noted in the descending colon (red arrow).
tis. Mild, self-limited watery diarrhea among
healthy individuals is the most common clinical
presentation followed by infective colitis, while
bacteremia is the most common extraintestinal
manifestation of Plesiomonas.1 Risk factors for
Plesiomonas bacteremia include blood dyscrasias, asplenia, iron overload, liver cirrhosis,
foreign travel, consumption of raw shellfish, old
age, underlying biliary tract disease and immunocompromised states.1,3-5 As of the review of
Janda, Abbott, and McIver from 2016,1 there
had been only over 40 cases of Plesiomonas
bacteremia in the literature, which is just double the amount published since the last review
in 1996.5

Case Presentation

A 78-year-old white female was evaluated for
generalized cramping abdominal pain of several
days duration. There was a past medical history
of hypertension, hyperlipidemia, multi-vessel
coronary artery disease, cardiac bypass surgery,
stent placement, sick sinus syndrome, paroxysmal atrial flutter, pacemaker placement and repaired rectovaginal fistula. She denied nausea,
fevers, chills, hematemesis and hematochezia.
There was no recent exposure to freshwater or
saltwater, including going to the beach, fishing,
traveling or seafood consumption.
Aside from diffuse abdominal tenderness, the
physical exam was mostly unremarkable, and
no gross signs of infection were noted. Initial
vitals were all within normal limits, and she
was afebrile (98.1°F). Labs were significant for
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leukocytosis (23.95 x 103/µL), lactic acidosis
(12.93 mmol/L) and procalcitonin elevation (4.11
ng/mL). Computed tomography (CT) of the
abdomen-pelvis and CT angiography of the
abdomen and pelvis both showed acute colitis
of the descending colon concerning possible
mesenteric ischemia. (Figure 1)
Given the above, surgery was consulted, and
the patient underwent emergent exploratory laparotomy. Necrosis of the entire colonic
distribution and the distal small bowel was
found, as well as left upper quadrant adhesions
to the spleen and diaphragm. The patient thus
underwent subtotal colectomy (ascending,
transverse, descending), splenectomy and
resection of the distal small bowel with an
ileostomy. Pathology of the small intestine and
colon demonstrated transmural infarction with
mucosal necrosis as well as acute transmural
inflammation. Serositis and serosal adhesions
were also noted throughout the intestines.
No evidence of malignancy was noted. Splenic
pathology was unremarkable.
The patient was started empirically on piperacillin-tazobactam and metronidazole. Blood
cultures taken on admission grew Plesiomonas
shigelloides. This isolate was susceptible to
cefepime, levofloxacin, ciprofloxacin and meropenem, using proposed MICs from the EUCAST Breakpoint Committee consultation on
Aeromonas and Plesiomonas breakpoints from
October 2017. More susceptibilities were recognized by the laboratory used by the hospital,
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including ceftriaxone and piperacillin-tazobactam, based on the CLSI 2019 interpretive criteria
against Pseudomonas aeruginosa, CLSI 2019
interpretive criteria against Enterobacteriaceae
and CLSI 2014 interpretive criteria for cefepime
against enterics.
Subsequent urinalysis was consistent with
infection, with urine cultures positive for
vancomycin-resistant Enterococcus faecium.
The patient was started on linezolid. Negative
blood cultures were obtained four days after
positive blood cultures. The patient was discharged with intravenous ertapenem and oral
metronidazole.

Discussion

Plesiomonas typically presents with diarrhea (88–99%), bloody diarrhea (5–45%),
fever(6–51%), abdominal pain (6–72%) and
vomiting(14–74%) based on a review of studies
from African and Asian countries.1 Aside from
the aforementioned manifestations of Plesiomonas, Plesiomonas has been implicated in
septic abortion and bacteremia in a 24-year-old
pregnant female who had recently traveled to
the Caribbean, and was involved in pyosalpinx
acquired in an immunocompetent patient from
swimming in contaminated water.6,7 It may be
a possible human pathogen in the setting of
water-related natural disasters, as it has been
isolated in water pumps after a tsunami and
isolated from a corpse after a typhoon.8,9 A
case of Plesiomonas pneumonia was reported
in 2009. At that time, the patient underwent
gastrectomy and esophageal-jejunostomy for
gastric adenocarcinoma and was admitted for
clinical signs of pulmonic infection. Bronchial
lavage of a cavernous lesion in the right upper
lobe showed granulocytic inflammation, and
culture was positive for Plesiomonas.10 Another
case describes a 51-year-old male who underwent liver transplantation who developed
Plesiomonas bacteremia. It was found that
the donor, a drowning victim, had Plesiomonas
bacteremia.11
There are few cases published regarding wound
infections. Various wound infections in the
literature include cutaneous abscess secondary to abrasions sustained from diving into
a rocky freshwater basin, infectious keratitis
when struck in the eye with creek bedrock, and

infection of laceration sustained from falling
into pondwater.12-14 It is hypothesized that the
lack of protease expression may contribute
to this organism’s infrequent association with
soft tissue infections and an injury is needed to
facilitate this type of infection.1 Regardless, the
majority of Plesiomonas infections, primarily
gastroenteritis, are self-limited.15
A study of 167 laboratory-confirmed cases
(98.8% of cases being gastroenteritis) found
that infections were sensitive to ofloxacin,
levofloxacin and ceftriaxone. Resistance was
found for ampicillin, tetracyclines, co-trimoxazole and chloramphenicol.15 One study found the
resistance of Plesiomonas to cephalosporins;
however, although beta-lactamase production
is noted, resistance was mostly attributed to
extensive filament formation.16
In this case, Plesiomonas was recovered only
from the blood. This patient had no reported
freshwater exposure, direct or indirect. The patient lacked many of the associated risk factors
and presented with significant colitis. Although
the patient did not report freshwater exposure, the possibility that the patient ingested
something with contaminated water exposure
cannot be excluded, and it can only be summarized that the consumption may have resulted
in gastroenteritis and subsequent seeding of
the blood. No guidelines-based therapy was
available for decision-making, which could have
been far more problematic given its relative
rarity and the acuity of the patient’s presentation.

Conclusion

Developing guideline-based therapy for extraintestinal manifestations of Plesiomonas
is difficult. Relative rarity, the variability of
presentation, presence or absence of underlying diseases, exposure to risk factors, currently limited data and the utilization of varying
antimicrobial regimens, all contribute to the
difficulty in outlining an appropriate treatment regimen. Future studies should focus on
better characterizing its presence in the United
States, additional risk factors and appropriate
antibiotic therapy.
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